Whether bioengineered organs from stem cells or 3D bioprinting will eliminate organ donor shortages.
Scope: Xenotransplantation, 3D bioprinting, stem cells, pig organs, clinical trials
The field of lab-grown organs, encompassing technologies like 3D bioprinting, stem cell-derived organoids, and xenotransplantation, is rapidly advancing. While significant scientific hurdles remain, preclinical and early-stage clinical trials indicate promising potential to address the critical shortage of organs for transplant. Current efforts are focused on improving organ functionality, reducing immune rejection, and scaling production.
What is the real reason for the sudden, unexplained "Great Silence" from the James Webb Space Telescope?
75%JWST went dark for 72 hours and NASA's explanations keep changing. Conspiracy theories range from a major discovery cover-up to a catastrophic failure.
Did COVID-19 leak from a lab?
75%The debate over SARS-CoV-2 origins — natural zoonotic spillover vs. Wuhan Institute of Virology lab leak.
Will room-temperature superconductors be achieved by 2030?
10%Monitoring progress toward room-temperature, ambient-pressure superconductors. Tracking LK-99 aftermath, hydride research under extreme pressures, and novel material discoveries.
Will nuclear fusion become commercially viable by 2035?
45%ITER, private companies (Commonwealth Fusion, TAE) — when will fusion deliver net energy to the grid?
Will CRISPR cure most genetic diseases by 2040?
75%Whether gene editing technology will advance enough to treat or cure the majority of inherited genetic conditions.
Will we find extraterrestrial life by 2040?
70%Whether definitive evidence of life beyond Earth — microbial or intelligent — will be discovered within the next 15 years.